Faculty & Scientific Staff
Carla Greenbaum, MD
Dr. Greenbaum is Director of the Diabetes Program and Center for Interventional Immunology at Benaroya Research Institute. After medical school at Brown University, she completed her endocrinology fellowship at the University of Washington. Dr. Greenbaum served as Chair of Type 1 Diabetes TrialNet, an NIH sponsored international consortium to test disease modifying therapies in T1D for the past 6 years, and is currently Director of the TrialNet Clinical Hub.
Area of Research
Dr. Greenbaum is a clinical investigator who works to alter the course of T1D through understanding the causes of disease, and testing interventions to alter immune mediated beta cell dysfunction. She has led or participated in multiple clinical trials of disease modifying therapy sponsored by academia and industry as well as proof of mechanism clinical research studies. Dr. Greenbaum’s expertise includes clinical trial design and implementation as well as discovery and evaluation of biomarkers for disease course and response to therapy.